awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34023704-65F6D423-3291-4BA5-BB08-B6D9FD180CA5
Q34023704-65F6D423-3291-4BA5-BB08-B6D9FD180CA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34023704-65F6D423-3291-4BA5-BB08-B6D9FD180CA5
Therapeutic options for HER-2 positive breast cancer: Perspectives and future directions
P2860
Q34023704-65F6D423-3291-4BA5-BB08-B6D9FD180CA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34023704-65F6D423-3291-4BA5-BB08-B6D9FD180CA5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b06c8b86799aefcbc5b390df5b00f0d9eff3f336
P2860
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized